Natural product-inspired fragment-based drug discovery: Development of M. tuberculosis CYP121 inhibitors

被引：0
|
作者：
Kavanagh, Madeline [1 ]
Gray, Janine [1 ]
Coyne, Anthony [1 ]
Davis, Holly [1 ]
McLean, Kirsty [2 ]
Munro, Andrew [2 ]
Abell, Christopher [1 ]
机构：
[1] Univ Cambridge, Dept Chem, Cambridge, England
[2] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
818
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Fragment-based drug discovery of potent and selective CYP121 inhibitors for tuberculosis
    Kavanagh, Madeline
    Coyne, Anthony
    James, Guy
    McLean, Kirsty
    Hudson, Sean
    de Carvalho, Luis Pedro
    Munro, Andrew
    Abell, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [2] Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors
    Kavanagh, Madeline E.
    Coyne, Anthony G.
    McLean, Kirsty J.
    James, Guy G.
    Levy, Colin W.
    Marino, Leonardo B.
    de Carvalho, Luiz Pedro S.
    Chan, Daniel S. H.
    Hudson, Sean A.
    Surade, Sachin
    Leys, David
    Munro, Andrew W.
    Abell, Chris
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (07) : 3272 - 3302
  • [3] Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products
    Prasasty, Vivitri Dewi
    Cindana, Sandra
    Ivan, Fransiskus Xaverius
    Zahroh, Hilyatuz
    Sinaga, Ernawati
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 85 (85)
  • [4] Substrate Fragmentation for the Design of M.tuberculosis CYP121 Inhibitors
    Kavanagh, Madeline E.
    Gray, Janine L.
    Gilbert, Sophie H.
    Coyne, Anthony G.
    McLean, Kirsty J.
    Davis, Holly J.
    Munro, Andrew W.
    Abell, Chris
    CHEMMEDCHEM, 2016, 11 (17) : 1924 - 1935
  • [5] Application of Fragment Screening and Merging to the Discovery of Inhibitors of the Mycobacterium tuberculosis Cytochrome P450 CYP121
    Hudson, Sean A.
    McLean, Kirsty J.
    Surade, Sachin
    Yang, Yong-Qing
    Leys, David
    Ciulli, Alessio
    Munro, Andrew W.
    Abell, Chris
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (37) : 9311 - 9316
  • [6] Discovery of Mycobacterium tuberculosis CYP121 New Inhibitor via Structure-Based Drug Repurposing
    El Moudaka, Tarek
    Murugan, Priya
    Rahman, Mohd Basyaruddin Abdul
    Tejo, Bimo Ario
    PERTANIKA JOURNAL OF SCIENCE AND TECHNOLOGY, 2023, 31 (03): : 1503 - 1521
  • [7] Spirooxindoles as novel 3D-fragment scaffolds: Synthesis and screening against CYP121 from M. tuberculosis
    Davis, Holly J.
    Kavanagh, Madeline E.
    Balan, Tudor
    Abell, Chris
    Coyne, Anthony G.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (15) : 3735 - 3740
  • [8] Natural product-inspired peptide drug discovery accelerated by the RaPID system
    Suga, Hiroaki
    CANCER RESEARCH, 2014, 74 (19)
  • [9] Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors
    Svensson, Fredrik
    Bender, Andreas
    Bailey, David
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1415 - 1424
  • [10] MEDICINAL CHEMISTRY INSPIRED FRAGMENT-BASED DRUG DISCOVERY
    Lanter, James
    Zhang, Xuqing
    Sui, Zhihua
    FRAGMENT-BASED DRUG DESIGN: TOOLS, PRACTICAL APPROACHES, AND EXAMPLES, 2011, 493 : 421 - 445
12345